The central position of estrogen in the physiological and pharmacological control of bone resorption is now challenged by evidence from mouse genetics of estrogen-independent control by pituitary FSH.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Albright, F. Smith, P.H. & Richardson, A.M. JAMA 116, 2465–2474 (1941).
Sun, L. et al. Cell 125, 247–260 (2006).
Danilovich, N. et al. Endocrinology 141, 4295–4308 (2000).
Manolagas, S.C. & Jilka, R.L. N. Engl. J. Med. 332, 305–311 (1995).
Eghbali-Fatourechi, G. et al. J. Clin. Invest. 111, 1221–1230 (2003).
Burger, H.G. et al. Recent Prog. Horm. Res. 57, 257–275 (2002).
Welt, C.K. et al. J. Clin. Endocrinol. Metab. 84, 105–111 (1999).
Gaddy-Kurten, D. et al. Endocrinology 143,74–83 (2002).
Perrien, D.S. et al. J. Clin. Endocrinol. Metab. 91, 1848–1854 (2006).
Ebeling, P.R. J. Clin. Endocrinol. Metab. 91, 1669–1670 (2006).
Vural, F. et al. Maturitas 52, 147–153 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, T., Gaddy, D. Bone loss goes beyond estrogen. Nat Med 12, 612–613 (2006). https://doi.org/10.1038/nm0606-612
Issue Date:
DOI: https://doi.org/10.1038/nm0606-612